Vicarious Surgical (RBOTW) Amortization of Deferred Charges (2021 - 2022)

Vicarious Surgical (RBOTW) reported Amortization of Deferred Charges of $50000.0 for Q4 2022, up 433.33% year-over-year from $9375.0 in Q4 2021, and up 525.0% quarter-over-quarter from $8000.0 in Q3 2022.

Vicarious Surgical (RBOTW) Amortization of Deferred Charges (2021 - 2022) Analysis & Trends

Vicarious Surgical (RBOTW) has 2 years of Amortization of Deferred Charges data on file, last reported at $50000.0 in Q4 2022.

  • Amortization of Deferred Charges for Q4 2022 came in at $50000.0, up 433.33% year-over-year; the trailing twelve-month figure through Dec 2022 was $75000.0 (changed N/A YoY), and the FY2022 annual result was $75000.0, up 257.14% from the prior year.
  • Amortization of Deferred Charges rose to $50000.0 in Q4 2022 per RBOTW's latest filing, from $8000.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $50000.0 in Q4 2022 and troughed at -$15000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Vicarious Surgical - - -

Historic Data

Download Data
DateValue
Dec 31, 2022 50,000.00
Dec 31, 2022 50,000.00
Sep 30, 2022 8,000.00
Sep 30, 2022 8,000.00
Jun 30, 2022 9,000.00
Jun 30, 2022 9,000.00
Mar 31, 2022 8,000.00
Mar 31, 2022 8,000.00
Dec 31, 2021 -15,000.00
Dec 31, 2021 -15,000.00
Sep 30, 2021 27,000.00
Sep 30, 2021 27,000.00